Comerica Bank
AGIO icon

Comerica Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Comerica Bank’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.7K Sell
209
-165
-44% -$5.79K ﹤0.01% 3377
2025
Q3 		$15K Buy
374
+21
+6% +$790 ﹤0.01% 3164
2025
Q2 		$11.7K Buy
353
+163
+86% +$4.94K ﹤0.01% 3172
2025
Q1 		$5.54K Buy
190
+10
+6% +$332 ﹤0.01% 3304
2024
Q4 		$5.9K Sell
180
-1
-0.6% -$47 ﹤0.01% 3285
2024
Q3 		$8.03K Sell
181
-40
-18% -$1.82K ﹤0.01% 3224
2024
Q2 		$9.51K Sell
221
-3
-1% -$108 ﹤0.01% 3168
2024
Q1 		$6.53K Buy
224
+157
+234% +$4.2K ﹤0.01% 3275
2023
Q4 		$1.49K Sell
67
-48
-42% -$1.08K ﹤0.01% 3573
2023
Q3 		$2.85K Buy
+115
New +$3.04K ﹤0.01% 3504
2019
Q3 		– Sell
-18,738
Closed -$909K – 2272
2019
Q2 		$909K Buy
18,738
+5,130
+38% +$274K 0.01% 1593
2019
Q1 		$871K Buy
+13,608
New +$793K 0.01% 1658

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Comerica Bank's AGIO Position: Q4 2025 in Review

Comerica Bank reduced its Agios Pharmaceuticals (AGIO) stake by 44% in Q4 2025, selling an estimated $5.79K and leaving 209 shares worth $5.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3377.

Comerica Bank first reported a position in AGIO in Q1 2019 and has held it in 12 quarters since. The position peaked at $909K in Q2 2019. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Comerica Bank held 209 shares of Agios Pharmaceuticals worth $5.7K as of Q4 2025.
  • Comerica Bank sold 165 Agios Pharmaceuticals shares in Q4 2025, an estimated $5.79K.
  • Agios Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3377 holding.
  • Comerica Bank first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 12 quarters since.
  • Comerica Bank's Agios Pharmaceuticals position peaked at $909K in Q2 2019.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.